You can:
Name | Orexin receptor type 2 |
---|---|
Species | Homo sapiens (Human) |
Gene | HCRTR2 |
Synonym | Ox-2-R OX2 receptor Ox2-R OX2R orexin receptor type 2 [ Show all ] |
Disease | Insomnia |
Length | 444 |
Amino acid sequence | MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW |
UniProt | O43614 |
Protein Data Bank | 5ws3, 5wqc, 4s0v, 4rnb |
GPCR-HGmod model | O43614 |
3D structure model | This structure is from PDB ID 5ws3. |
BioLiP | BL0303710, BL0398950, BL0397818, BL0302679 |
Therapeutic Target Database | T69485 |
ChEMBL | CHEMBL4792 |
IUPHAR | 322 |
DrugBank | BE0005865 |
Name | CID 44405017 |
---|---|
Molecular formula | C128H211N45O35S |
IUPAC name | (2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]propanoyl]amino]propanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-N-[(2S)-1-[[2-[(2S)-2-[(2S)-2-[[2-[[(2S)-1-[[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]pentanediamide |
Molecular weight | 2972.44 |
Hydrogen bond acceptor | 41 |
Hydrogen bond donor | 42 |
XlogP | -12.2 |
Synonyms | N/A |
Inchi Key | AACMUARQDPOIFF-JXHOBYDLSA-N |
Inchi ID | InChI=1S/C128H211N45O35S/c1-16-65(10)101(170-119(202)84(47-64(8)9)169-124(207)102(69(14)176)171-107(190)73(129)37-43-209-15)123(206)149-53-96(181)152-66(11)104(187)153-67(12)106(189)163-86(49-71-52-141-60-151-71)118(201)168-87(50-95(133)180)110(193)147-55-98(183)156-88(58-174)120(203)154-68(13)105(188)159-79(32-35-93(131)178)113(196)165-83(46-63(6)7)116(199)166-82(45-62(4)5)115(198)161-77(28-21-40-144-128(139)140)111(194)162-80(33-36-94(132)179)114(197)167-85(48-70-51-145-74-25-18-17-24-72(70)74)117(200)160-76(27-20-39-143-127(137)138)108(191)146-54-97(182)155-78(31-34-92(130)177)112(195)164-81(44-61(2)3)109(192)150-57-100(185)172-41-23-30-91(172)125(208)173-42-22-29-90(173)122(205)148-56-99(184)157-89(59-175)121(204)158-75(103(134)186)26-19-38-142-126(135)136/h17-18,24-25,51-52,60-69,73,75-91,101-102,145,174-176H,16,19-23,26-50,53-59,129H2,1-15H3,(H2,130,177)(H2,131,178)(H2,132,179)(H2,133,180)(H2,134,186)(H,141,151)(H,146,191)(H,147,193)(H,148,205)(H,149,206)(H,150,192)(H,152,181)(H,153,187)(H,154,203)(H,155,182)(H,156,183)(H,157,184)(H,158,204)(H,159,188)(H,160,200)(H,161,198)(H,162,194)(H,163,189)(H,164,195)(H,165,196)(H,166,199)(H,167,197)(H,168,201)(H,169,207)(H,170,202)(H,171,190)(H4,135,136,142)(H4,137,138,143)(H4,139,140,144)/t65-,66-,67-,68-,69+,73-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,101-,102-/m0/s1 |
PubChem CID | 44405017 |
ChEMBL | CHEMBL437149 |
IUPHAR | N/A |
BindingDB | 50121817 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 0.15 nM | PMID12467628 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417